Tocagen (Tocagen) FCF Margin % : 0.00% (As of Mar. 2020)

View and export this data going back to 2017. Start your Free Trial

What is Tocagen FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Tocagen's Free Cash Flow for the three months ended in Mar. 2020 was $-7.07 Mil. Tocagen's Revenue for the three months ended in Mar. 2020 was $0.00 Mil. Therefore, Tocagen's FCF Margin % for the quarter that ended in Mar. 2020 was 0.00%.

As of today, Tocagen's current FCF Yield % is 0.00%.

The historical rank and industry rank for Tocagen's FCF Margin % or its related term are showing as below:

TOCA' s FCF Margin % Range Over the Past 10 Years
Min: -181185.19 Med: 0 Max: 0
Current: -181185.19

TOCA's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -147.18 vs TOCA: -181185.19

Tocagen FCF Margin % Historical Data

The historical data trend for Tocagen's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tocagen FCF Margin % Chart

Tocagen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

FCF Margin %

-41,711.76

-61,355.10

-77,531.71

-202.02

-165,738.89

Tocagen Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
FCF Margin %	Get a 7-Day Free Trial													-197,944.44	-203,166.67	-142,822.22	-119,022.22	-

Competitive Comparison of Tocagen's FCF Margin %

For the Biotechnology subindustry, Tocagen's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tocagen's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tocagen's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Tocagen's FCF Margin % falls into.

Tocagen FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Tocagen's FCF Margin for the fiscal year that ended in Dec. 2019 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2019 )	/	Revenue (A: Dec. 2019 )
	=	-59.666	/	0.036
	=	-165,738.89 %

Tocagen's FCF Margin for the quarter that ended in Mar. 2020 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2020 )	/	Revenue (Q: Mar. 2020 )
	=	-7.069	/	0
	=	%

Tocagen FCF Margin % Related Terms

Thank you for viewing the detailed overview of Tocagen's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tocagen (Tocagen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tocagen Inc (NAS:TOCA) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4242 Campus Point Court, Suite 500, San Diego, CA, USA, 92121

Website

http://www.tocagen.com

Tocagen Inc is a clinical-stage, cancer-selective gene therapy company. It is focused on developing product candidates designed to activate a patient's immune system against their own cancer from within. The company's cancer-selective gene therapy platform is built on retroviral replicating vectors, or RRVs, which are designed to selectively deliver therapeutic genes into the DNA of cancer cells. Tocagen is developing product candidate, Toca 511 and Toca FC, for the treatment of recurrent high grade glioma, or HGG, a brain cancer with limited treatment options, low survival rates and, therefore, a significant unmet medical need. Geographically, the activities are carried out through United States.